(19)
(11) EP 3 592 352 A1

(12)

(43) Date of publication:
15.01.2020 Bulletin 2020/03

(21) Application number: 18712467.2

(22) Date of filing: 07.03.2018
(51) International Patent Classification (IPC): 
A61K 31/465(2006.01)
A61K 9/00(2006.01)
A24B 15/16(2020.01)
A61K 45/06(2006.01)
(86) International application number:
PCT/IB2018/051482
(87) International publication number:
WO 2018/163085 (13.09.2018 Gazette 2018/37)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 07.03.2017 US 201715452133

(71) Applicant: Philip Morris Products S.A.
2000 Neuchâtel (CH)

(72) Inventors:
  • STENZLER, Alex
    Long Beach, CA 90804 (US)
  • ZAMEL, Noe
    Toronto, Ontario M2M 2T1 (CA)
  • SLUTSKY, Arthur
    Toronto, Ontario M5R 3T5 (CA)
  • ELLIS, Steven
    Oro-Medonte, Ontario L0L 2E0 (CA)
  • HAN, Steve
    Huntington Beach, CA 92648 (US)

(74) Representative: Nytko-Lutz, Emily Anne 
Reddie & Grose LLP The White Chapel Building 10 Whitechapel High Street
London E1 8QS
London E1 8QS (GB)

   


(54) INHALABLE NICOTINE FORMULATIONS, AND METHODS OF MAKING AND USING THEREOF